Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990473850> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2990473850 endingPage "144" @default.
- W2990473850 startingPage "136" @default.
- W2990473850 abstract "Tisagenlecleucel is a CD19-specific chimeric antigen receptor (CAR)-T cell therapy approved for patients aged ≤25 years with relapsed or refractory B cell precursor acute lymphoblastic leukemia (B-ALL) and adults with relapsed or refractory diffuse large B cell lymphoma (DLBCL). The initial tisagenlecleucel manufacturing process technology was developed at an academic center and was subsequently transferred, optimized, validated, and scaled out to supply large global trials before commercialization. Tisagenlecleucel manufactured in two centralized facilities has been successfully used in global multicenter trials for B-ALL and DLBCL (>50 clinical centers in 12 countries). In this paper, we describe some of the continuous process improvements made to tisagenlecleucel manufacturing over time to meet global demand while maintaining and improving product quality. During early tisagenlecleucel clinical trials, process enhancements were made to address logistical challenges related to manufacturing for multicenter trials and to accommodate the variability observed in patient starting cellular material. These enhancements resulted in improvements in manufacturing capacity, process robustness, manufacturing success rates, and product quality, and reductions in throughput time. In summary, through continuous evaluation and improvements based on experience during global trials, a consistent and robust commercial manufacturing process for tisagenlecleucel has been developed, leading to improvements in manufacturing success when compared to the initial processes." @default.
- W2990473850 created "2019-12-05" @default.
- W2990473850 creator A5006845401 @default.
- W2990473850 creator A5011107073 @default.
- W2990473850 creator A5044341455 @default.
- W2990473850 date "2020-03-01" @default.
- W2990473850 modified "2023-10-13" @default.
- W2990473850 title "Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials" @default.
- W2990473850 cites W1767113662 @default.
- W2990473850 cites W1967517831 @default.
- W2990473850 cites W2105400883 @default.
- W2990473850 cites W2118796952 @default.
- W2990473850 cites W2130011407 @default.
- W2990473850 cites W2145985838 @default.
- W2990473850 cites W2167550136 @default.
- W2990473850 cites W2305384511 @default.
- W2990473850 cites W2567664749 @default.
- W2990473850 cites W2623114472 @default.
- W2990473850 cites W2760653955 @default.
- W2990473850 cites W2773804840 @default.
- W2990473850 cites W2787301955 @default.
- W2990473850 cites W2792281539 @default.
- W2990473850 cites W2891902322 @default.
- W2990473850 cites W2903062212 @default.
- W2990473850 doi "https://doi.org/10.1016/j.omtm.2019.11.018" @default.
- W2990473850 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6970133" @default.
- W2990473850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31988978" @default.
- W2990473850 hasPublicationYear "2020" @default.
- W2990473850 type Work @default.
- W2990473850 sameAs 2990473850 @default.
- W2990473850 citedByCount "75" @default.
- W2990473850 countsByYear W29904738502020 @default.
- W2990473850 countsByYear W29904738502021 @default.
- W2990473850 countsByYear W29904738502022 @default.
- W2990473850 countsByYear W29904738502023 @default.
- W2990473850 crossrefType "journal-article" @default.
- W2990473850 hasAuthorship W2990473850A5006845401 @default.
- W2990473850 hasAuthorship W2990473850A5011107073 @default.
- W2990473850 hasAuthorship W2990473850A5044341455 @default.
- W2990473850 hasBestOaLocation W29904738501 @default.
- W2990473850 hasConcept C126322002 @default.
- W2990473850 hasConcept C203014093 @default.
- W2990473850 hasConcept C2778559949 @default.
- W2990473850 hasConcept C2779338263 @default.
- W2990473850 hasConcept C535046627 @default.
- W2990473850 hasConcept C71924100 @default.
- W2990473850 hasConceptScore W2990473850C126322002 @default.
- W2990473850 hasConceptScore W2990473850C203014093 @default.
- W2990473850 hasConceptScore W2990473850C2778559949 @default.
- W2990473850 hasConceptScore W2990473850C2779338263 @default.
- W2990473850 hasConceptScore W2990473850C535046627 @default.
- W2990473850 hasConceptScore W2990473850C71924100 @default.
- W2990473850 hasLocation W29904738501 @default.
- W2990473850 hasLocation W29904738502 @default.
- W2990473850 hasLocation W29904738503 @default.
- W2990473850 hasLocation W29904738504 @default.
- W2990473850 hasOpenAccess W2990473850 @default.
- W2990473850 hasPrimaryLocation W29904738501 @default.
- W2990473850 hasRelatedWork W2131100258 @default.
- W2990473850 hasRelatedWork W2274060198 @default.
- W2990473850 hasRelatedWork W2745048239 @default.
- W2990473850 hasRelatedWork W2795974062 @default.
- W2990473850 hasRelatedWork W2906855825 @default.
- W2990473850 hasRelatedWork W2907448176 @default.
- W2990473850 hasRelatedWork W4200407604 @default.
- W2990473850 hasRelatedWork W4295756220 @default.
- W2990473850 hasRelatedWork W4312019992 @default.
- W2990473850 hasRelatedWork W61785916 @default.
- W2990473850 hasVolume "16" @default.
- W2990473850 isParatext "false" @default.
- W2990473850 isRetracted "false" @default.
- W2990473850 magId "2990473850" @default.
- W2990473850 workType "article" @default.